Wei Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Physiology top 2%
Papers in
-
- RNA modifications and cancer 19
- Cancer therapeutics and mechanisms 17
- Gut microbiota and health 11
- Epidemiology 45
- Herpesvirus Infections and Treatments 12
- Co-authors
- Wendy Keung (1 shared paper)Liyan Zhang (1 shared paper)Victor Samokhvalov (1 shared paper)Gary D. Lopaschuk (1 shared paper)Hua Tian (19 shared papers)Shaoguo Ru (18 shared papers)Qi Zhou (1 shared paper)Jianzhong Xiao (1 shared paper)
- Journals
- Scientific Reports (12 papers)PLoS ONE (8 papers)Advanced Science (7 papers)Medicine (6 papers)Ecotoxicology and Environmental Safety (6 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Wang
528 papers receiving 7.0k citations
Wei Wang's Hit Papers
Peers
Comparison fields: 5 of 186
- Cancer Research 694
- Physiology 159
- Molecular Biology 2.3k
- Immunology 576
- Oncology 635
Countries citing papers authored by Wei Wang
This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).
Fields of papers citing papers by Wei Wang
This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 592 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 230 | |
| 2 | Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy Hit paper breakdown → | 2024 | 219 |
| 3 | 2005 | 199 | |
| 4 | 2004 | 146 | |
| 5 | 2020 | 140 | |
| 6 | 2012 | 122 | |
| 7 | 2020 | 111 | |
| 8 | 2006 | 102 | |
| 9 | 2007 | 99 | |
| 10 | 2019 | 95 | |
| 11 | 2018 | 93 | |
| 12 | 2013 | 92 | |
| 13 | 2019 | 90 | |
| 14 | 2017 | 88 | |
| 15 | 2021 | 82 | |
| 16 | Histone lactylation: from tumor lactate metabolism to epigenetic regulation Hit paper breakdown → | 2024 | 74 |
| 17 | Zr‐MOF Carrier‐Enhanced Dual‐Mode Biosensing Platforms for Rapid and Sensitive Diagnosis of Mpox Hit paper breakdown → | 2024 | 73 |
| 18 | 2022 | 71 | |
| 19 | 2012 | 70 | |
| 20 | 2020 | 68 |
About Wei Wang
Wei Wang is a scholar working on Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 592 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), Thyroid Disorders and Treatments (19 papers), RNA modifications and cancer (19 papers), Cancer therapeutics and mechanisms (17 papers), Reproductive biology and impacts on aquatic species (14 papers), Lymphoma Diagnosis and Treatment (13 papers), Herpesvirus Infections and Treatments (12 papers) and Gut microbiota and health (11 papers). The work is most often cited by research in Cancer Research (694 citations), Physiology (159 citations), Molecular Biology (2.3k citations), Immunology (576 citations) and Oncology (635 citations). Wei Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wendy Keung, Liyan Zhang, Victor Samokhvalov, Gary D. Lopaschuk, Hua Tian, Shaoguo Ru, Qi Zhou, Jianzhong Xiao, Quan Shi and Gangyi Liu. Their work appears in journals such as Scientific Reports, PLoS ONE, Advanced Science, Medicine and Ecotoxicology and Environmental Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.